pe
pep-05244 v1 CC-BY-SA-4.0

Locustin anticancer peptide

A peptide studied in the lab for its ability to kill or slow cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length55 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.406
avg pLDDT54.5
ranking score0.517
STRUCTURE · PEP-05244 × ANTICANCER
ranking0.517
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence55 aa
1510152025303540455055
ATTGCSCPQCI IFDPICASSYK NGRRGFSSGCH MRCYNRCHGTD YFQISKGSKCI
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.5168974995613098 boltz-2
3-letter notation
Ala-Thr-Thr-Gly-Cys-Ser-Cys-Pro-Gln-Cys-Ile-Ile-Phe-Asp-Pro-Ile-Cys-Ala-Ser-Ser-Tyr-Lys-Asn-Gly-Arg-Arg-Gly-Phe-Ser-Ser-Gly-Cys-His-Met-Arg-Cys-Tyr-Asn-Arg-Cys-His-Gly-Thr-Asp-Tyr-Phe-Gln-Ile-Ser-Lys-Gly-Ser-Lys-Cys-Ile
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Locustin anticancer peptide (pep-05244, v1). PeptideModel. https://peptidemodel.com/card/pep-05244
@peptide{pep05244,
  sequence = {ATTGCSCPQCIIFDPICASSYKNGRRGFSSGCHMRCYNRCHGTDYFQISKGSKCI},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use